An interventional study of CAS Treatment for Minimally Verbal Children with Autism in Developmental Verbal Dyspraxia and Autism Spectrum Disorder, sponsored by MGH Institute of Health Professions. Recruiting at 1 site in United States. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-03-30.
Sponsored by MGH Institute of Health Professions · Not applicable, Interventional, and Treatment
Comorbid Childhood Apraxia of Speech (CAS) may be one factor that limits speech development in some minimally verbal children with autism. CAS is a disorder affecting speech movement planning. This study tests whether CAS-specific treatment, appropriately modified for minimally verbal children with autism, improves their speech.
Although one in four children with autism remain minimally verbal past age five, not all the factors that limit spoken language in these minimally verbal children are known. One powerful contributor may be a motor speech disorder, Childhood Apraxia of Speech (CAS). CAS is an impairment in the ability to plan and sequence for speech, which makes speech inconsistent and imprecise. This project proposes to investigate whether CAS makes the speech of minimally verbal children with autism unintelligible, and then to test whether treating the CAS improves children's speech.
First, a cohort of 20 minimally verbal children with both autism and CAS is identified. The prediction is that the more severe the CAS, the more inconsistent and imprecise a child's speech, and therefore the lower their intelligibility will be. Then, a set of mono- and bisyllabic words is selected that contain the disordered movements that each child shows and use those in treatment.
Treatment will take the form of 15 one-hour sessions where speech practice is embedded in a naturalistic, play-based milieu that is centered on each child's own developmental level. It will involve principles of motor learning (intensive practice of a few words, sometimes all in a row and sometimes mixed up). Different types of cues (touch cues, simultaneous production, etc.) will also be employed to help children say their words correctly, fading back these supports as the child's speech improves. Both of these techniques have been shown to be effective for treating CAS.
Our outcome measures will include both (1) "by-ear" assessments of intelligibility and (2) acoustic and kinematic measurements of children's speech after 15 treatment sessions. The findings will inform clinical practice for minimally verbal children with autism and may lead to the development of novel interventions for this severely affected population.
65 studies on the registry are indexed under Apraxias; 21 are open to participants now.
This study's planned enrollment of 20 is below the median of 32 across 50 interventional studies indexed under Apraxias.
Browse Apraxias studies →MGH Institute of Health Professions is the lead sponsor of 19 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants will receive CAS treatment, modified for minimally verbal children with autism
Behavioral: CAS Treatment for Minimally Verbal Children with Autism
Treatment involves principles of motor learning embedded in a naturalistic developmental milieu
Attempts Correct
Number or percent of target items that were produced correctly
Time frame: 5 weeks
Phonemes Correct
Number or percent of phonemes (vowels, consonants) in the target items that were produced correctly
Time frame: 5 weeks
Lip aperture movement variability
Amount of variability in lip opening area during production of multiple attempts at the same target
Time frame: 5 weeks
Phoneme distinctiveness
Acoustic distinctiveness of different phonemes
Time frame: 5 weeks
Plan to share: No
No publications or documents are linked to this record.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
MGH Institute of Health Professions